Antibiotics

Europe to tackle antimicrobial resistance

Friday 20 January 2012

Interviewee/Contributer: Nigel Gaymond

Full text available to subscribers only. Click here for information on subscribing to MedNous.

The perilous state of antibiotic development

Friday 20 January 2012

Interviewee/Contributer: Helen Boucher

Organisation: Infectious Diseases Society of America (IDSA)

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Antimicrobial resistance: finding solutions

Sunday 10 April 2011

Interviewee/Contributer: 

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Finding solutions to drug resistance

Monday 4 April 2011

Interviewee/Contributer: Laura Smart

Organisation: Tiber Creek Partners LLC

Full text available to subscribers only. Click here for information on subscribing to MedNous.

A new paradigm for antibiotic drug development

Monday 22 November 2010

Interviewee/Contributer: John Lisman

Organisation: Lisman Legal Life Sciences

Full text available to subscribers only. Click here for information on subscribing to MedNous.

The search continues for new antibiotics

Monday 22 November 2010

Interviewee/Contributer: Ted Bianco

Organisation: Wellcome Trust

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Novacta targets C. difficile the natural way

Wednesday 6 May 2009

Interviewee/Contributer: Tony Sedgwick

Organisation: Novacta Biosystems Ltd

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Novacta targets C. difficile the natural way

Wednesday 6 May 2009

Interviewee/Contributer: Michael Dawson

Organisation: Novacta Biosystems Ltd

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Wellcome Trust rises to the antibiotic challenge

Friday 10 October 2008

Interviewee/Contributer: Ted Bianco

Organisation: Wellcome Trust

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Syndicate content